Skip to main content
OpenTrials

Clinical trial condition

Liver Diseases

Explore clinical trials studying Liver Diseases. Study availability and eligibility vary by location and protocol.

590 public trials 87 recruiting studies
Refine in advanced search Browse all conditions

Liver Diseases trial results

Active, Not Recruiting

TReatment for ImmUne Mediated PathopHysiology

NCT04862221

Conditions
Acute Liver Failure, Acute Liver Injury, Brain Diseases, +13 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Lucile Packard Children's Hospital Palo Alto, California, United States
  • Rady Children's Hospital San Diego, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With Bulevirtide

NCT07128550

Conditions
Chronic Disease, Digestive System Diseases, Disease Attributes, +12 more
Locations
  • Investigative Site Innsbruck, Austria
  • Investigative Site Vienna, Austria
  • Investigative Site Bobigny, France
  • Investigative Site Clichy, France
View all 38 locations
View Trial Details
Active, Not Recruiting

A Study Evaluating Atezolizumab, With or Without Bevacizumab, in Participants With Unresectable Hepatocellular Carcinoma and Child-pugh B7 and B8 Cirrhosis

NCT06096779

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of Southern California-Keck School of Medicine -1975 Zonal Ave Los Angeles, California, United States
  • University of Southern California Newport Beach, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

NCT04849728

Conditions
Digestive System Diseases, Fatty Liver, Fibrosis, +5 more
Locations
  • Objective Health - Birmingham Gastroenterology Associates Birmingham, Alabama, United States
  • Digestive Health Specialist of the Southeast Dothan, Alabama, United States
  • North Alabama GI Research Center llc Madison, Alabama, United States
  • The Institute For Liver Health - Chandler Chandler, Arizona, United States
View all 459 locations
View Trial Details
Active, Not Recruiting

TheraSphere With Durvalumab and Tremelimumab for HCC

NCT05063565

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • University of Arizona- Banner Health Tucson, Arizona, United States
  • University of California San Diego San Diego, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Georgetown University Washington D.C., District of Columbia, United States
View all 36 locations
View Trial Details
Active, Not Recruiting

A Study of Lepodisiran (LY3819469) in Participants With Normal, Mild, Moderate, or Severe Liver Function

NCT06916078

Conditions
Digestive System Diseases, Healthy, Liver Diseases, +1 more
Locations
  • Clinical Pharmacology of Miami Miami, Florida, United States
  • Orlando Clinical Research Center Orlando, Florida, United States
  • American Research Corporation at Texas Liver Institute San Antonio, Texas, United States
  • CRU Early Phase Unit Kistarcsa, Hungary
View Trial Details
Active, Not Recruiting

Restrictive Fluid Management In Liver Transplantation (REFIL) - Pilot

NCT05647733

Conditions
Digestive System Diseases, End Stage Liver Disease, End-stage Liver Disease (ESLD), +4 more
Locations
  • Vancouver General Hospital Vancouver, British Columbia, Canada
  • London Health Sciences Centre London, Ontario, Canada
  • Centre Hospitalier de l'Université de Montréal (CHUM) Montreal, Quebec, Canada
  • McGill University Health Centre Montreal, Quebec, Canada
View Trial Details

Related conditions